Singapore - English - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - mirabegron - tablet, film coated, extended release - 25 mg - mirabegron 25 mg

Singapore - English - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - mirabegron - tablet, film coated, extended release - 50 mg - mirabegron 50 mg

Malta - English - Medicines Authority

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - solifenacin succinate - film-coated tablet - solifenacin succinate 5 mg - urologicals

Malta - English - Medicines Authority

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - solifenacin succinate - film-coated tablet - solifenacin succinate 10 mg - urologicals

European Union - English - EMA (European Medicines Agency)

astellas pharma europe b.v. - mirabegron - urinary bladder, overactive - urologicals - symptomatic treatment of urgency.increased micturition frequency and / or urgency incontinence as may occur in adult patients with overactive-bladder syndrome.

European Union - English - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - capecitabine - stomach neoplasms; breast neoplasms; colonic neoplasms; colorectal neoplasms - capecitabine - capecitabine is indicated for the adjuvant treatment of patients following surgery of stage-iii (dukes’ stage-c) colon cancer.capecitabine is indicated for the treatment of metastatic colorectal cancer.capecitabine is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. capecitabine is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

resene paints (australia) limited - copper present as cuprous thiocyanate; copper present as cuprous thiocyanate; copper present as cuprous thiocyanate; copper present as cuprous thiocyanate; copper present as cuprous thiocyanate; zinc pyrithione; zinc pyrithione; zinc pyrithione; zinc pyrithione; zinc pyrithione - paint - copper present as cuprous thiocyanate cyanide active 226.0 g/l; copper present as cuprous thiocyanate cyanide active 228.0 g/l; copper present as cuprous thiocyanate cyanide active 247.0 g/l; copper present as cuprous thiocyanate cyanide active 247.0 g/l; copper present as cuprous thiocyanate cyanide active 251.0 g/l; zinc pyrithione mineral-zinc active 48.5 g/l; zinc pyrithione mineral-zinc active 49.5 g/l; zinc pyrithione mineral-zinc active 44.6 g/l; zinc pyrithione mineral-zinc active 48.5 g/l; zinc pyrithione mineral-zinc active 43.7 g/l - antifouling

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -